Commentary: A Cell Line for Detection of Botulinum Neurotoxin Type B

Commentary: A Cell Line for Detection of Botulinum Neurotoxin Type B

Bibliographic Details
Main Author:	Andy Pickett
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-09-01
Series:	Frontiers in Pharmacology
Subjects:	botulinum toxin potency assay mouse assay alternative assay commercial issues
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2018.01056/full

Similar Items

An Ultrasensitive Gold Nanoparticle-based Lateral Flow Test for the Detection of Active Botulinum Neurotoxin Type A
by: Jing Liu, et al.
Published: (2017-03-01)

Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins
by: Osnat Rosen, et al.
Published: (2016-09-01)

Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays
by: Maren Schenke, et al.
Published: (2020-04-01)

Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction
by: Elisa Duregotti, et al.
Published: (2015-12-01)

Docking Simulation and Sandwich Assay for Aptamer-Based Botulinum Neurotoxin Type C Detection
by: In-Hwan Oh, et al.
Published: (2020-08-01)

A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes
by: Consuelo Garcia-Rodriguez, et al.
Published: (2018-03-01)

Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN)
by: Hans Bigalke, et al.
Published: (2015-11-01)

Comparison of botulinum neurotoxin type A formulations in Asia
by: Frevert J, et al.
Published: (2018-07-01)

Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B
by: Luisa W. Cheng, et al.
Published: (2015-11-01)

Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection
by: Michael J. Perry, et al.
Published: (2017-03-01)

Engineering of Botulinum Neurotoxins for Biomedical Applications
by: Robert P. Webb
Published: (2018-06-01)

Development of a novel, rapid, in vitro assay for the detection of Clostridium botulinum neurotoxin type E
by: Cadieux, Brigitte.
Published: (2001)

Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
by: Ames C. Register, et al.
Published: (2021-05-01)

A Rapid, Sensitive, and Portable Biosensor Assay for the Detection of Botulinum Neurotoxin Serotype A in Complex Food Matrices
by: Christina C. Tam, et al.
Published: (2018-11-01)

Functional Assessment of Cord Blood Units Using Two Different Assays
by: Chandra Viswanathan, et al.
Published: (2012-07-01)

Therapy of Sialorrhea with Botulinum Neurotoxin
by: Wolfgang H. Jost, et al.
Published: (2019-09-01)

Use of Botulinum Neurotoxin in Ophthalmology
by: Emel Başar, et al.
Published: (2016-12-01)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
by: John Tapia-Núñez, et al.
Published: (2012-11-01)

Botulinum Neurotoxin Injections in Childhood Opisthotonus
by: Mariam Hull, et al.
Published: (2021-02-01)

Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development
by: Christine Rasetti-Escargueil, et al.
Published: (2021-12-01)

Biotoxin Detection Using Cell-Based Sensors
by: Pratik Banerjee, et al.
Published: (2013-11-01)

A Cell Line for Detection of Botulinum Neurotoxin Type B
by: Aleksander Rust, et al.
Published: (2017-11-01)

Probiotic Microorganisms Inhibit Epithelial Cell Internalization of Botulinum Neurotoxin Serotype A
by: Tina I. Lam, et al.
Published: (2016-12-01)

Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics
by: Juliette Duchesne de Lamotte, et al.
Published: (2021-07-01)

Botulinum neurotoxin formulations: overcoming the confusion
by: Samizadeh S, et al.
Published: (2018-05-01)

Regulatory Perspective on Bioassay Implementation Strategies for Potency Evaluation of Biopharmaceuticals
by: Alessandra Pepe
Published: (2021-01-01)

Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson’s Disease: An Updated Review
by: Steven D. Mitchell, et al.
Published: (2021-03-01)

A Strategy to Replace the Mouse Bioassay for Detecting and Identifying Lipophilic Marine Biotoxins by Combining the Neuro-2a Bioassay and LC-MS/MS Analysis
by: Marcia Bodero, et al.
Published: (2018-12-01)

Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures
by: Katharine E. Alter, et al.
Published: (2017-12-01)

A critical assessment of the estrogenic potency of benzyl salicylate
by: Andreas Natsch, et al.
Published: (2021-01-01)

Mutagenic properties of dimethylaniline isomers in mice as evaluated by comet, micronucleus and transgenic mutation assays
by: Arihiro Kohara, et al.
Published: (2018-08-01)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
by: Gabriella Egeo, et al.
Published: (2020-08-01)

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
by: Jorge Jacinto, et al.
Published: (2020-05-01)

Immunological detection assays for recombinant Shiga toxin & Shigella dysenteriae
by: Pallavi Gupta, et al.
Published: (2019-01-01)

VALIDATION OF ANALYTICAL METHOD OF ASSAY OF SERPISTEN IN OINTMENT
by: E. I. Molokhova, et al.
Published: (2019-01-01)

Selection of appropriate analytical tools to determine the potency and bioactivity of antibiotics and antibiotic resistance
by: Nishant A. Dafale, et al.
Published: (2016-08-01)

Mass spectrometric identification and differentiation of botulinum neurotoxins through toxin proteomics
by: Kalb Suzanne R., et al.
Published: (2013-08-01)

A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A
by: Jianlong Lou, et al.
Published: (2018-02-01)

Botulinum Neurotoxin Diversity from a Gene-Centered View
by: Roger M. Benoit
Published: (2018-08-01)

Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients’ Characteristics
by: Marta Tarazona-Motes, et al.
Published: (2021-08-01)